O63 EFFICACY AND SAFETY OF THE ALL-ORAL REGIMEN, MK-5172/MK-8742 +/− RBV FOR 12 WEEKS IN GT1 HCV/HIV CO-INFECTED PATIENTS: THE C-WORTHY STUDY.

Authors :: Sulkowski, M.
Mallolas, J.
Pol, S.
Bourliere, M.
Gerstoft, J.
Shibolet, O.
Nahass, R.
DeJesus, E.
Shaughnessy, M.
Hwang, P.
Wahl, J.
Robertson, M.N.
Haber, B.
Source :: Journal of Hepatology. Apr2014 Supplement, Vol. 60, pS26-S26. 1p.
Publication Year :: 2014

Subjects :: *EXPERIMENTAL medicine
*DRUG efficacy
*MEDICATION safety
*ORAL drug administration
*HEPATITIS C treatment

Full Text Access

Tools